Inventor
Stephanie Schulz
Inventor
West Chester, PA, US
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides19%
A61KPreparations for medical, dental or toiletry purposes18%
G01NInvestigating or analysing materials by determining their chemical or physical properties18%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
C12NMicroorganisms or enzymes14%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms14%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
PatentTitleYear
9,429,576'Compositions and methods for identifying and targeting cancer cells of alimentary canal origin'20168,946,168'Compositions and methods for identifying and targeting cancer cells of alimentary canal origin'20158,206,704'Use of GCC ligands'20128,067,007'Compositions and methods for identifying and targeting cancer cells of alimentary canal origin'20117,854,933'Compositions and methods for identifying and targeting cancer cells of alimentary canal origin'20107,829,276'Methods of using CRCA-1 as a stomach and esophageal cancer marker'20107,785,817'Compositions and methods for identifying and targeting cancer cells of alimentary canal origin'20107,745,114'Compositions and methods for identifying and targeting cancer cells of alimentary canal origin'20107,485,422'Detection of CDX2 expression'20097,479,376'Compositions and methods for identifying and targeting cancer cells of alimentary canal origin'20097,316,902'Compositions that specifically bind to colorectal cancer cells and methods of using the same'20087,135,333'Compositions that specifically bind to colorectal cancer cells and methods of using the same'20066,844,153'Compositions and methods for identifying and targeting cancer cells of alimentary canal origin'20056,767,704'Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression'20046,120,995'Compositions that specifically bind to colorectal cancer cells and methods of using the same'20005,237,051'Purified enterotoxin receptor protein'1993Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1993Based in Dallas, TX, US· patent location history
2000–2016Patents assigned to UNIV JEFFERSON (14)· patent assignee history
2000–2016Based in West Chester, PA, US· patent location history
2010Based in Philadelphia, PA, US· patent location history
2011–2015Patents assigned to PARK JASON (3)· patent assignee history
2011–2015Patents assigned to SCHULZ STEPHANIE (3)· patent assignee history
2011–2015Patents assigned to WALDMAN SCOTT A (3)· patent assignee history
2012Patents assigned to LUBBE WILHELM (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV JEFFERSON | 14 | 2000–2016 |
| PARK JASON | 3 | 2011–2015 |
| SCHULZ STEPHANIEself | 3 | 2011–2015 |
| WALDMAN SCOTT A | 3 | 2011–2015 |
| LUBBE WILHELM | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| West Chester, Pennsylvania, US | 14 | 2000–2016 |
| Philadelphia, Pennsylvania, US | 1 | 2010 |
| Dallas, Texas, US | 1 | 1993 |